Decreased levels of low-density lipoprotein cholesterol (LDL-C) in the use of low and moderate-intensity statin in type2 diabetic patients treated in community hospital.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230101001

Enrollment

Registered

2023-01-01

Start date

2022-05-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The reduction of LDL-C levels of low and moderate intensity statin drugs in type 2 diabetic patients in community hospital statins, intensity, LDL, diabetes mellitus

Interventions

Patients receiving low intensity statins were simvastatin 10 mg,Patients receiving moderate intensity statins were simvastatin (10, 20, or 40 mg) or atorvastatin 20 mg

Treatment,Treatment

low intensity statin group,moderate intensity statin group

Eligibility

Sex/Gender

All

Age

15 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Type 2 diabetic patient in Bangbo hospital 2. Age > 15 year olds 3.LDL-C before treatment > 100 mg/dl 4. Treatment of hyperlipidemia with simvastatin (10, 20, 40 mg ) or atorvastatin 20 mg 5. Received at least 3 months of treatment, and LDL-C levels were monitored before and at least 3 months after dosing

Exclusion criteria

Exclusion criteria: 1. Patients without LDL-C testing before and after drug administration 2. Patients were previously treated with statins elsewhere.

Design outcomes

Primary

Measure	Time frame
reduction of LDL-C levels 3 months LDL-C levels	—

Secondary

Measure	Time frame
n/a n/a n/a	—

Countries

Thailand

Contacts

Public ContactChudsanee Pongmongkol

Bangbo hospital

hammingging@gmail.com023381133

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026